These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23112868)

  • 1. Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.
    Wu L; Rowley J; Mohades S; Leuzy A; Dauar MT; Shin M; Fonov V; Jia J; Gauthier S; Rosa-Neto P;
    PLoS One; 2012; 7(10):e47905. PubMed ID: 23112868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment.
    He B; Wang L; Xu B; Zhang Y;
    Neurosci Lett; 2021 May; 754():135765. PubMed ID: 33667602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid deposition, hypometabolism, and longitudinal cognitive decline.
    Landau SM; Mintun MA; Joshi AD; Koeppe RA; Petersen RC; Aisen PS; Weiner MW; Jagust WJ;
    Ann Neurol; 2012 Oct; 72(4):578-86. PubMed ID: 23109153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural MRI markers and cognitive decline in prodromal Alzheimer's disease: a 2-year longitudinal study.
    Wei H; Kong M; Zhang C; Guan L; Ba M;
    Quant Imaging Med Surg; 2018 Nov; 8(10):1004-1019. PubMed ID: 30598878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.
    Murphy KR; Landau SM; Choudhury KR; Hostage CA; Shpanskaya KS; Sair HI; Petrella JR; Wong TZ; Doraiswamy PM;
    Neuroimage; 2013 Sep; 78():474-80. PubMed ID: 23624169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
    Altmann A; Ng B; Landau SM; Jagust WJ; Greicius MD;
    Brain; 2015 Dec; 138(Pt 12):3734-46. PubMed ID: 26419799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
    Furukawa K; Okamura N; Tashiro M; Waragai M; Furumoto S; Iwata R; Yanai K; Kudo Y; Arai H
    J Neurol; 2010 May; 257(5):721-7. PubMed ID: 19946781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?
    Nowell J; Raza S; Livingston NR; Sivanathan S; Gentleman S; Edison P
    J Alzheimers Dis; 2024; 101(3):987-999. PubMed ID: 39302365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.
    Massa F; Martinuzzo C; Gómez de San José N; Pelagotti V; Kreshpa W; Abu-Rumeileh S; Barba L; Mattioli P; Orso B; Brugnolo A; Girtler N; Vigo T; Arnaldi D; Serrati C; Uccelli A; Morbelli S; Chincarini A; Otto M; Pardini M
    J Neurol; 2024 Apr; 271(4):1999-2009. PubMed ID: 38157030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.
    Baran TM; Lin FV;
    J Alzheimers Dis; 2018; 66(1):307-318. PubMed ID: 30282358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
    Huang KL; Lin KJ; Hsiao IT; Kuo HC; Hsu WC; Chuang WL; Kung MP; Wey SP; Hsieh CJ; Wai YY; Yen TC; Huang CC
    PLoS One; 2013; 8(3):e58974. PubMed ID: 23516589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
    Sörensen A; Blazhenets G; Rücker G; Schiller F; Meyer PT; Frings L;
    Neuroimage Clin; 2019; 21():101637. PubMed ID: 30553760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
    Zhou Y; Yu F; Duong TQ;
    J Magn Reson Imaging; 2015 Jan; 41(1):102-9. PubMed ID: 24382798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
    Brendel M; Pogarell O; Xiong G; Delker A; Bartenstein P; Rominger A;
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):716-24. PubMed ID: 25631614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Default Mode Network Functional Connectivity in Early and Late Mild Cognitive Impairment: Results From the Alzheimer's Disease Neuroimaging Initiative.
    Lee ES; Yoo K; Lee YB; Chung J; Lim JE; Yoon B; Jeong Y;
    Alzheimer Dis Assoc Disord; 2016; 30(4):289-296. PubMed ID: 26840545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
    Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY
    Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered amplitude of low-frequency fluctuations in early and late mild cognitive impairment and Alzheimer's disease.
    Liang P; Xiang J; Liang H; Qi Z; Li K; Alzheimer's Disease NeuroImaging Initiative
    Curr Alzheimer Res; 2014 May; 11(4):389-98. PubMed ID: 24720892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
    Jing J; Zhang F; Zhao L; Xie J; Chen J; Zhong R; Zhang Y; Dong C
    J Alzheimers Dis; 2021; 79(3):1317-1325. PubMed ID: 33427748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer's Disease.
    Tedeschi Dauar M; Pascoal TA; Therriault J; Rowley J; Mohaddes S; Shin M; Zimmer ER; Eskildsen SF; Fonov VS; Gauthier S; Poirier J; Rosa-Neto P;
    Brain Sci; 2023 Jan; 13(2):. PubMed ID: 36831775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.